SIRT1 and prostate neoplasm: The resulting pro-inflammatory milieu significantly suppresses prostate tumor growth, an effect diminished when IFN-γ and CXCL10 pathways are inhibited, highlighting SIRT1’s role in immune-mediated tumor suppression.